The TN Controlled Substance Monitoring Database (CSMD) rules have been amended effective this week. The amendment requires that all healthcare practitioners, unless otherwise exempted, check the CSMD prior to issuing a Schedule II amphetamine, at the beginning of a new episode of treatment; prior to the issuance of each new prescribing for the first 90 days of a new episode of treatment; and at least every 6 months during that course of treatment.
This rule change means that Schedule II amphetamines constitute a third class of drugs (others being opioids and benzodiazepines) triggering a check and is the result of the CSMD Committee's determination that Schedule II amphetamines demonstrate a high potential for abuse. As with opioids and benzos, an authorized healthcare practitioner's delegate may check the controlled substance database on behalf of the practitioner who is prescribing Schedule II amphetamines. (Credit: Julie Loomis, RN, JD, SVMIC AVP of Risk Education)
|
|